{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:06:38Z","timestamp":1762506398781},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T00:00:00Z","timestamp":1408060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00774-014-0603-9","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T15:05:01Z","timestamp":1408028701000},"page":"432-439","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial"],"prefix":"10.1007","volume":"33","author":[{"given":"Michio","family":"Hongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kasukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"603_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jocn.2009.06.013","volume":"17","author":"S Ohtori","year":"2010","unstructured":"Ohtori S, Akazawa T, Murata Y, Kinoshita T, Yamashita M, Nakagawa K, Inoue G, Nakamura J, Orita S, Ochiai N, Kishida S, Takaso M, Eguchi Y, Yamauchi K, Suzuki M, Aoki Y, Takahashi K (2010) Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. J Clin Neurosci 17:209\u2013213","journal-title":"J Clin Neurosci"},{"key":"603_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01352009","volume":"53","author":"M Meschia","year":"1993","unstructured":"Meschia M, Brincat M, Barbacini P, Crossignani PG, Albisetti W (1993) A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women. Calcif Tissue Int 53:17\u201320","journal-title":"Calcif Tissue Int"},{"key":"603_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02556587","volume":"38","author":"GF Mazzuoli","year":"1986","unstructured":"Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli R, Valtorta C, Palummeri E, Cervellin GF, Gonnelli S, Francini G (1986) Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 38:3\u20138","journal-title":"Calcif Tissue Int"},{"key":"603_CR4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-004-1798-8","volume":"16","author":"JA Knopp","year":"2005","unstructured":"Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH (2005) Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16:1281\u20131290","journal-title":"Osteoporos Int"},{"key":"603_CR5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjmed.2004.05.019","volume":"117","author":"Y Ishida","year":"2004","unstructured":"Ishida Y, Kawai S (2004) Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: the Yamaguchi Osteoporosis Prevention Study. Am J Med 117:549\u2013555","journal-title":"Am J Med"},{"key":"603_CR6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00002512-199608050-00006","volume":"8","author":"GL Plosker","year":"1996","unstructured":"Plosker GL, McTavish D (1996) Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis. Drugs Aging 8:378\u2013400","journal-title":"Drugs Aging"},{"key":"603_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00774-011-0259-7","volume":"29","author":"T Fujita","year":"2011","unstructured":"Fujita T, Ohue M, Nakajima M, Fujii Y, Miyauchi A, Takagi Y (2011) Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36. J Bone Miner Metab 29:588\u2013597","journal-title":"J Bone Miner Metab"},{"key":"603_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00198-011-1676-0","volume":"23","author":"JA Knopp-Sihota","year":"2012","unstructured":"Knopp-Sihota JA, Newburn-Cook CV, Homik J, Cummings GG, Voaklander D (2012) Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Osteoporos Int 23:17\u201338","journal-title":"Osteoporos Int"},{"key":"603_CR9","doi-asserted-by":"crossref","unstructured":"Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD004523","DOI":"10.1002\/14651858.CD004523.pub3"},{"key":"603_CR10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1248\/bpb.b12-00200","volume":"35","author":"M Takakuwa","year":"2012","unstructured":"Takakuwa M, Iwamoto J (2012) Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. Biol Pharm Bull 35:1159\u20131165","journal-title":"Biol Pharm Bull"},{"key":"603_CR11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337","journal-title":"J Bone Miner Metab"},{"key":"603_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0025-6196(12)61173-2","volume":"66","author":"PJ Limburg","year":"1991","unstructured":"Limburg PJ, Sinaki M, Rogers JW, Caskey PE, Pierskalla BK (1991) A useful technique for measurement of back strength in osteoporotic and elderly patients. Mayo Clin Proc 66:39\u201344","journal-title":"Mayo Clin Proc"},{"key":"603_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-009-0125-z","volume":"28","author":"K Kumamoto","year":"2010","unstructured":"Kumamoto K, Nakamura T, Suzuki T, Gorai I, Fujinawa O, Ohta H, Shiraki M, Yoh K, Fujiwara S, Endo N, Matsumoto T (2010) Validation of the Japanese Osteoporosis Quality of Life Questionnaire. J Bone Miner Metab 28:1\u20137","journal-title":"J Bone Miner Metab"},{"key":"603_CR14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00198-003-1510-4","volume":"14","author":"N Miyakoshi","year":"2003","unstructured":"Miyakoshi N, Itoi E, Kobayashi M, Kodama H (2003) Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis. Osteoporos Int 14:1007\u20131012","journal-title":"Osteoporos Int"},{"key":"603_CR15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02555844","volume":"49","author":"GP Lyritis","year":"1991","unstructured":"Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, Yiatzides A, Tsekoura M (1991) Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. Calcif Tissue Int 49:369\u2013372","journal-title":"Calcif Tissue Int"},{"key":"603_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/17453674.1997.11744761","volume":"275","author":"GP Lyritis","year":"1997","unstructured":"Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG (1997) Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl 275:112\u2013114","journal-title":"Acta Orthop Scand Suppl"},{"key":"603_CR17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00002508-199912000-00004","volume":"15","author":"GP Lyritis","year":"1999","unstructured":"Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, Kataxaki E, Papaioannou N, Kaloudis J, Galanos A (1999) Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 15:284\u2013289","journal-title":"Clin J Pain"},{"key":"603_CR18","first-page":"12","volume":"12","author":"M Abellan Perez","year":"1995","unstructured":"Abellan Perez M, Bayina Garcia FJ, Calabozo M, Carpintero Benitez P, Figueroa Pedrosa M, Fernandez Crisostomo C, Garcia Lopez A, Garcia Perez S, Mesa Ramos M, Paulino Tevar J et al (1995) Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis. An Med Interna 12:12\u201316","journal-title":"An Med Interna"},{"key":"603_CR19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/archinte.165.12.1363","volume":"165","author":"DK Wysowski","year":"2005","unstructured":"Wysowski DK, Chang JT (2005) Alendronate and risedronate: reports of severe bone, joint, and muscle pain. Arch Intern Med 165:346\u2013347","journal-title":"Arch Intern Med"},{"key":"603_CR20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00774-012-0372-2","volume":"30","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Osawa M, Itoh M, Yamaguchi H, Iinuma N, Hayakawa Y, Suzuki H, Kamisaki T, Iwayama S, Nishikawa M (2012) The effect of risedronate (17.5\u00a0mg\/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study. J Bone Miner Metab 30:715\u2013721","journal-title":"J Bone Miner Metab"},{"key":"603_CR21","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00198-011-1856-y","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Zanchetta JR, Russo L, Recknor CP, Saag KG, McKiernan FE, Silverman SL, Alam J, Burge RT, Krege JH, Lakshmanan MC, Masica DN, Mitlak BH, Stock JL (2012) The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporos Int 23:2141\u20132150","journal-title":"Osteoporos Int"},{"key":"603_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-005-2013-2","volume":"17","author":"MC Nevitt","year":"2006","unstructured":"Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17:273\u2013280","journal-title":"Osteoporos Int"},{"key":"603_CR23","first-page":"459","volume":"6","author":"AE Pontiroli","year":"1994","unstructured":"Pontiroli AE, Pajetta E, Scaglia L, Rubinacci A, Resmini G, Arrigoni M, Pozza G (1994) Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study. Aging (Milano) 6:459\u2013463","journal-title":"Aging (Milano)"},{"key":"603_CR24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00586-005-0916-4","volume":"15","author":"G Papadokostakis","year":"2006","unstructured":"Papadokostakis G, Damilakis J, Mantzouranis E, Katonis P, Hadjipavlou A (2006) The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. Eur Spine J 15:356\u2013362","journal-title":"Eur Spine J"},{"key":"603_CR25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s001980200118","volume":"13","author":"SL Silverman","year":"2002","unstructured":"Silverman SL, Azria M (2002) The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int 13:858\u2013867","journal-title":"Osteoporos Int"},{"key":"603_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s007740070026","volume":"18","author":"M Yoshimura","year":"2000","unstructured":"Yoshimura M (2000) Analgesic mechanism of calcitonin. J Bone Miner Metab 18:230\u2013233","journal-title":"J Bone Miner Metab"},{"key":"603_CR27","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1523\/JNEUROSCI.20-16-06302.2000","volume":"20","author":"A Ito","year":"2000","unstructured":"Ito A, Kumamoto E, Takeda M, Shibata K, Sagai H, Yoshimura M (2000) Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J Neurosci 20:6302\u20136308","journal-title":"J Neurosci"},{"key":"603_CR28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10067-006-0228-z","volume":"26","author":"D Ofluoglu","year":"2007","unstructured":"Ofluoglu D, Akyuz G, Unay O, Kayhan O (2007) The effect of calcitonin on beta-endorphin levels in postmenopausal osteoporotic patients with back pain. Clin Rheumatol 26:44\u201349","journal-title":"Clin Rheumatol"},{"key":"603_CR29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00558497","volume":"37","author":"R Franceschini","year":"1989","unstructured":"Franceschini R, Cataldi A, Barreca T, Salvemini M, Rolandi E (1989) Plasma beta-endorphin, ACTH and cortisol secretion in man after nasal spray administration of calcitonin. Eur J Clin Pharmacol 37:341\u2013343","journal-title":"Eur J Clin Pharmacol"},{"key":"603_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-2007-1012291","volume":"18","author":"L Laurian","year":"1986","unstructured":"Laurian L, Oberman Z, Graf E, Gilad S, Hoerer E, Simantov R (1986) Calcitonin induced increase in ACTH, beta-endorphin and cortisol secretion. Horm Metab Res 18:268\u2013271","journal-title":"Horm Metab Res"},{"key":"603_CR31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/endo-127-2-621","volume":"127","author":"GV Shah","year":"1990","unstructured":"Shah GV, Wang W, Grosvenor CE, Crowley WR (1990) Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+. Endocrinology 127:621\u2013628","journal-title":"Endocrinology"},{"key":"603_CR32","first-page":"103","volume-title":"osteoporosis","author":"N Miyakoshi","year":"2012","unstructured":"Miyakoshi N, Hongo M, Shimada Y (2012) Prevalence of back pain in postmenopausal osteoporosis and associations with multiple spinal factors. In: Dionyssiotis Y (ed) osteoporosis. InTech, Rijeka, pp 103\u2013114"},{"key":"603_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00296-006-0288-z","volume":"27","author":"JD Ringe","year":"2007","unstructured":"Ringe JD, Farahmand P, Schacht E, Rozehnal A (2007) Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int 27:425\u2013434","journal-title":"Rheumatol Int"},{"key":"603_CR34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00774-012-0406-9","volume":"31","author":"S Itoh","year":"2013","unstructured":"Itoh S, Sekino Y, Shinomiya K, Takeda S (2013) The effects of risedronate administered in combination with a proton pump inhibitor for the treatment of osteoporosis. J Bone Miner Metab 31:206\u2013211","journal-title":"J Bone Miner Metab"},{"key":"603_CR35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00198-004-1744-9","volume":"16","author":"NM Schoor van","year":"2005","unstructured":"van Schoor NM, Smit JH, Twisk JW, Lips P (2005) Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study. Osteoporos Int 16:749\u2013756","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0603-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-014-0603-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0603-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:39:25Z","timestamp":1565735965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-014-0603-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s00774-014-0603-9","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]}}}